Normative Oculomotor and Vestibular Data in Pediatric Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-01

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to use a device called I-Portal® Portable Assessment System (I-PAS) to record eye movements in response to a number of visual and auditory stimuli designed to evaluate neural brain pathways related to oculomotor, vestibular, reaction time and cognitive (OVRT-C) development. The goal of this research is to collect normative data for the OVRT-C tests from a healthy pediatric population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)

NCT03529799

Mild Traumatic Brain Injury

TERMINATED NA

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

NCT05476523

Eye Movement

RECRUITING

Oculomotor Assessment of Traumatic Brain Injury (TBI)

NCT03156010

Traumatic Brain Injury

COMPLETED NA

Vestibular Testing: Consistency and Effects Over Time

NCT03182868

Dizziness

COMPLETED NA

Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy

NCT04046523

Intracranial Pressure Increase

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

I-PAS

I-PAS is a portable, head-mounted display goggle system with integrated eye tracking technology. I-PAS records eye movements in response to visual and auditory stimuli.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or females age 6 to 18 years of all races.
* Parental/guardian permission (informed consent) and child assent

Exclusion Criteria

* History of head injury characterized by any of the following:

1. Resulting from penetrating trauma
2. Resulting from an automobile accident with significant associated injuries
3. Associated with a Glasgow Comma Scale Score of less than 13 at the time of injury
4. Associated with a loss of consciousness period greater than 30 minutes
5. Judged to be more than mild by medical staff
6. Requiring admission to the hospital for any reason
7. Associated with subdural or epidural hemorrhage
8. Persons with a previous history of mTBI in the past and who were symptomatic prior to current injury
* Pregnancy, as documented by last menstrual period at study visits
* Implants: Persons implanted with an electrical and/or neurostimulator device, including but not limited to cardiac pacemaker, defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, bone growth stimulator, or cochlear implant, metal cervical spine hardware
* Diagnosed with attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, major depression, hypochondriasis, bipolar disorders, or schizophrenia.
* Presence of severe aphasia or inability to follow commands and give independent responses
* Documented neurodegenerative disorders (Multiple sclerosis, Parkinson's, Alzheimer's, Huntington)
* Past history of seizures or convulsions
* Prior disorders of hearing and balance including:

1. Meniere's disease
2. Multiple sclerosis
3. Vestibular neuritis
4. Vestibular schwannoma
5. Sudden sensorineural hearing loss
6. History of ear operation other than myringotomy and tube placement in the past
7. Acute or chronic disease of middle ear (infections, otitis)
* History of cerebrovascular disorders including stroke, brainstem or cerebellar dysfunction within the last 3 months
* Systemic disorders that include chronic renal failure, cirrhosis of the liver, autoimmune disease, heart disease, lung disease, severe arthritis, diabetes, hypertension
* Repeated history of syncope
* Past or concomitant treatment with ototoxic chemotherapy
* Previous contraindicating surgeries at the discretion of the study physician
* Aminoglycosides in the past 6 months given via systemic or transtympanic administration
* Concomitant treatment with any of the followings within the last 24 hours prior to testing if more than 2 doses have been taken:

1. Antihistamines: e.g. diphenhydramine, cyclizine, dimenhydrinate, meclizine, hydroxyzine, promethazine,
2. For ADHD and narcolepsy: e.g. Concerta, Daytrana, Methylin, Ritalin, Ritalin LA, Metadate ER, Aptensio XR, Cotempla XR-ODT, QuilliChew ER, and Quillivant XR
3. For schizophrenia and other mental diseases: e.g. Phenothiazines
4. Specific antibiotics: e.g. ethambutol, gentamycin
5. Anticonvulsant medications: e.g. topiramate
* Currently suffering from dehydration
* History or suspicion of substance abuse or addiction
* Acute alcohol intoxication
* Playing professional sports at the Olympic/league level

Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes